[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1298 Reported in House (RH)]

                                                  Union Calendar No. 38
108th CONGRESS
  1st Session
                                H. R. 1298

                          [Report No. 108-60]

    To provide assistance to foreign countries to combat HIV/AIDS, 
           tuberculosis, and malaria, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 17, 2003

Mr. Hyde (for himself, Mr. Lantos, Mr. Weldon of Florida, Ms. Lee, and 
  Mr. Leach) introduced the following bill; which was referred to the 
                  Committee on International Relations

                             April 7, 2003

  Reported with an amendment, committed to the Committee of the Whole 
       House on the State of the Union, and ordered to be printed
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]
 [For text of introduced bill, see copy of bill as introduced on March 
                               17, 2003]

_______________________________________________________________________

                                 A BILL


 
    To provide assistance to foreign countries to combat HIV/AIDS, 
           tuberculosis, and malaria, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``United States 
Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.
Sec. 2. Findings.
Sec. 3. Definitions.
Sec. 4. Purpose.
Sec. 5. Authority to consolidate and combine reports.

               TITLE I--POLICY PLANNING AND COORDINATION

Sec. 101. Development of a comprehensive, five-year, global strategy.
Sec. 102. HIV/AIDS Response Coordinator.

TITLE II--SUPPORT FOR MULTILATERAL FUNDS, PROGRAMS, AND PUBLIC-PRIVATE 
                              PARTNERSHIPS

Sec. 201. Sense of Congress on public-private partnerships.
Sec. 202. Participation in the Global Fund to Fight AIDS, Tuberculosis 
                            and Malaria.
Sec. 203. Voluntary contributions to international vaccine funds.

                      TITLE III--BILATERAL EFFORTS

              Subtitle A--General Assistance and Programs

Sec. 301. Assistance to combat HIV/AIDS.
Sec. 302. Assistance to combat tuberculosis.
Sec. 303. Assistance to combat malaria.
Sec. 304. Pilot program for the placement of health care professionals 
                            in overseas areas severely affected by HIV/
                            AIDS, tuberculosis, and malaria.
Sec. 305. Report on treatment activities by relevant executive branch 
                            agencies.

            Subtitle B--Assistance for Children and Families

Sec. 311. Findings.
Sec. 312. Policy and requirements.
Sec. 313. Annual reports on prevention of mother-to-child transmission 
                            of the HIV infection.
Sec. 314. Pilot program of assistance for children and families 
                            affected by HIV/AIDS.
Sec. 315. Pilot program on family survival partnerships.

               TITLE IV--AUTHORIZATION OF APPROPRIATIONS

Sec. 401. Authorization of appropriations.
Sec. 402. Sense of Congress.
Sec. 403. Allocation of funds.

SEC. 2. FINDINGS.

    Congress makes the following findings:
            (1) During the last 20 years, HIV/AIDS has assumed pandemic 
        proportions, spreading from the most severely affected regions, 
        sub-Saharan Africa and the Caribbean, to all corners of the 
        world, and leaving an unprecedented path of death and 
        devastation.
            (2) According to the Joint United Nations Programme on HIV/
        AIDS (UNAIDS), more than 65,000,000 individuals worldwide have 
        been infected with HIV since the epidemic began, more than 
        25,000,000 of these individuals have lost their lives to the 
        disease, and more than 14,000,000 children have been orphaned 
        by the disease. HIV/AIDS is the fourth-highest cause of death 
        in the world.
            (3)(A) At the end of 2002, an estimated 42,000,000 
        individuals were infected with HIV or living with AIDS, of 
        which more than 75 percent live in Africa or the Caribbean. Of 
        these individuals, more than 3,200,000 were children under the 
        age of fifteen and more than 19,200,000 were women.
            (B) Women are four times more vulnerable to infection than 
        are men and are becoming infected at increasingly high rates, 
        in part because many societies do not provide poor women and 
        young girls with the social, legal, and cultural protections 
        against high risk activities that expose them to HIV/AIDS.
            (C) Women and children who are refugees or are internally 
        displaced persons are especially vulnerable to sexual 
        exploitation and violence, thereby increasing the possibility 
        of HIV infection.
            (4) As the leading cause of death in sub-Saharan Africa, 
        AIDS has killed more than 19,400,000 individuals (more than 3 
        times the number of AIDS deaths in the rest of the world) and 
        will claim the lives of one-quarter of the population, mostly 
        adults, in the next decade.
            (5) An estimated 2,000,000 individuals in Latin America and 
        the Caribbean and another 7,100,000 individuals in Asia and the 
        Pacific region are infected with HIV or living with AIDS. 
        Infection rates are rising alarmingly in Eastern Europe 
        (especially in the Russian Federation), Central Asia, and 
        China.
            (6) HIV/AIDS threatens personal security by affecting the 
        health, lifespan, and productive capacity of the individual and 
        the social cohesion and economic well-being of the family.
            (7) HIV/AIDS undermines the economic security of a country 
        and individual businesses in that country by weakening the 
        productivity and longevity of the labor force across a broad 
        array of economic sectors and by reducing the potential for 
        economic growth over the long term.
            (8) HIV/AIDS destabilizes communities by striking at the 
        most mobile and educated members of society, many of whom are 
        responsible for security at the local level and governance at 
        the national and subnational levels as well as many teachers, 
        health care personnel, and other community workers vital to 
        community development and the effort to combat HIV/AIDS. In 
        some countries the overwhelming challenges of the HIV/AIDS 
        epidemic are accelerating the outward migration of critically 
        important health care professionals.
            (9) HIV/AIDS weakens the defenses of countries severely 
        affected by the HIV/AIDS crisis through high infection rates 
        among members of their military forces and voluntary 
        peacekeeping personnel. According to UNAIDS, in sub-Saharan 
        Africa, many military forces have infection rates as much as 
        five times that of the civilian population.
            (10) HIV/AIDS poses a serious security issue for the 
        international community by--
                    (A) increasing the potential for political 
                instability and economic devastation, particularly in 
those countries and regions most severely affected by the disease;
                    (B) decreasing the capacity to resolve conflicts 
                through the introduction of peacekeeping forces because 
                the environments into which these forces are introduced 
                pose a high risk for the spread of HIV/AIDS; and
                    (C) increasing the vulnerability of local 
                populations to HIV/AIDS in conflict zones from 
                peacekeeping troops with HIV infection rates 
                significantly higher than civilian populations.
            (11) The devastation wrought by the HIV/AIDS pandemic is 
        compounded by the prevalence of tuberculosis and malaria, 
        particularly in developing countries where the poorest and most 
        vulnerable members of society, including women, children, and 
        those individuals living with HIV/AIDS, become infected. 
        According to the World Health Organization (WHO), HIV/AIDS, 
        tuberculosis, and malaria accounted for more than 5,700,000 
        deaths in 2001 and caused debilitating illnesses in millions 
        more.
            (12) Together, HIV/AIDS, tuberculosis, malaria and related 
        diseases are undermining agricultural production throughout 
        Africa. According to the United Nations Food and Agricultural 
        Organization, 7,000,000 agricultural workers throughout 25 
        African countries have died from AIDS since 1985. Countries 
        with poorly developed agricultural systems, which already face 
        chronic food shortages, are the hardest hit, particularly in 
        sub-Saharan Africa, where high HIV prevalence rates are 
        compounding the risk of starvation for an estimated 14,400,000 
        people.
            (13) Tuberculosis is the cause of death for one out of 
        every three people with AIDS worldwide and is a highly 
        communicable disease. HIV infection is the leading threat to 
        tuberculosis control. Because HIV infection so severely weakens 
        the immune system, individuals with HIV and latent tuberculosis 
        infection have a 100 times greater risk of developing active 
        tuberculosis diseases thereby increasing the risk of spreading 
        tuberculosis to others. Tuberculosis, in turn, accelerates the 
        onset of AIDS in individuals infected with HIV.
            (14) Malaria, the most deadly of all tropical parasitic 
        diseases, has been undergoing a dramatic resurgence in recent 
        years due to increasing resistance of the malaria parasite to 
        inexpensive and effective drugs. At the same time, increasing 
        resistance of mosquitoes to standard insecticides makes control 
        of transmission difficult to achieve. The World Health 
        Organization estimates that between 300,000,000 and 500,000,000 
        new cases of malaria occur each year, and annual deaths from 
        the disease number between 2,000,000 and 3,000,000. Persons 
        infected with HIV are particularly vulnerable to the malaria 
        parasite. The spread of HIV infection contributes to the 
        difficulties of controlling resurgence of the drug resistant 
        malaria parasite.
            (15) HIV/AIDS is first and foremost a health problem. 
        Successful strategies to stem the spread of the HIV/AIDS 
        pandemic will require clinical medical interventions, the 
        strengthening of health care delivery systems and 
        infrastructure, and determined national leadership and 
        increased budgetary allocations for the health sector in 
        countries affected by the epidemic as well as measures to 
        address the social and behavioral causes of the problem and its 
        impact on families, communities, and societal sectors.
            (16) Basic interventions to prevent new HIV infections and 
        to bring care and treatment to people living with AIDS, such as 
        voluntary counseling and testing and mother-to-child 
        transmission programs, are achieving meaningful results and are 
        cost-effective. The challenge is to expand these interventions 
        from a pilot program basis to a national basis in a coherent 
        and sustainable manner.
            (17) Appropriate treatment of individuals with HIV/AIDS can 
        prolong the lives of such individuals, preserve their families, 
        prevent children from becoming orphans, and increase 
        productivity of such individuals by allowing them to lead 
        active lives and reduce the need for costly hospitalization for 
        treatment of opportunistic infections caused by HIV.
            (18) Nongovernmental organizations, including faith-based 
        organizations, with experience in health care and HIV/AIDS 
        counseling, have proven effective in combating the HIV/AIDS 
        pandemic and can be a resource in assisting indigenous 
        organizations in severely affected countries in their efforts 
        to provide treatment and care for individuals infected with 
        HIV/AIDS.
            (19) Faith-based organizations are making an important 
        contribution to HIV prevention and AIDS treatment programs 
        around the world. Successful HIV prevention programs in Uganda, 
        Jamaica, and elsewhere have included local churches and faith-
        based groups in efforts to promote behavior changes to prevent 
        HIV, to reduce stigma associated with HIV infection, to treat 
        those afflicted with the disease, and to care for orphans. The 
        Catholic Church alone currently cares for one in four people 
        being treated for AIDS worldwide. Faith-based organizations 
        possess infrastructure, experience, and knowledge that will be 
        needed to carry out these programs in the future and should be 
        an integral part of United States efforts.
            (20)(A) Uganda has experienced the most significant decline 
        in HIV rates of any country in Africa, including a decrease 
        among pregnant women from 20.6 percent in 1991 to 7.9 percent 
        in 2000.
            (B) Uganda made this remarkable turnaround because 
        President Yoweri Museveni spoke out early, breaking long-
        standing cultural taboos, and changed widespread perceptions 
        about the disease. His leadership stands as a model for ways 
        political leaders in Africa and other developing countries can 
        mobilize their nations, including civic organizations, 
        professional associations, religious institutions, business and 
        labor to combat HIV/AIDS.
            (C) Uganda's successful AIDS treatment and prevention 
        program is referred to as the ABC model: ``Abstain, Be 
        faithful, use Condoms'', in order of priority. Jamaica, Zambia, 
        Ethiopia and Senegal have also successfully used the ABC model. 
        Beginning in 1986, Uganda brought about a fundamental change in 
sexual behavior by developing a low-cost program with the message: 
``Stop having multiple partners. Be faithful. Teenagers, wait until you 
are married before you begin sex.''.
            (D) By 1995, 95 percent of Ugandans were reporting either 
        one or zero sexual partners in the past year, and the 
        proportion of sexually active youth declined significantly from 
        the late 1980s to the mid-1990s. The greatest percentage 
        decline in HIV infections and the greatest degree of behavioral 
        change occurred in those 15 to 19 years old. Uganda's success 
        shows that behavior change, through the use of the ABC model, 
        is a very successful way to prevent the spread of HIV.
            (21) The magnitude and scope of the HIV/AIDS crisis demands 
        a comprehensive, long-term, international response focused upon 
        addressing the causes, reducing the spread, and ameliorating 
        the consequences of the HIV/AIDS pandemic, including--
                    (A) prevention and education, care and treatment, 
                basic and applied research, and training of health care 
                workers, particularly at the community and provincial 
                levels, and other community workers and leaders needed 
                to cope with the range of consequences of the HIV/AIDS 
                crisis;
                    (B) development of health care infrastructure and 
                delivery systems through cooperative and coordinated 
                public efforts and public and private partnerships;
                    (C) development and implementation of national and 
                community-based multisector strategies that address the 
                impact of HIV/AIDS on the individual, family, 
                community, and nation and increase the participation of 
                at-risk populations in programs designed to encourage 
                behavioral and social change and reduce the stigma 
                associated with HIV/AIDS; and
                    (D) coordination of efforts between international 
                organizations such as the Global Fund to Fight AIDS, 
                Tuberculosis and Malaria, the Joint United Nations 
                Programme on HIV/AIDS (UNAIDS), the World Health 
                Organization (WHO), national governments, and private 
                sector organizations, including faith-based 
                organizations.
            (22) The United States has the capacity to lead and enhance 
        the effectiveness of the international community's response 
        by--
                    (A) providing substantial financial resources, 
                technical expertise, and training, particularly of 
                health care personnel and community workers and 
                leaders;
                    (B) promoting vaccine and microbicide research and 
                the development of new treatment protocols in the 
                public and commercial pharmaceutical research sectors;
                    (C) making available pharmaceuticals and 
                diagnostics for HIV/AIDS therapy;
                    (D) encouraging governments and faith-based and 
                community-based organizations to adopt policies that 
                treat HIV/AIDS as a multisectoral public health problem 
                affecting not only health but other areas such as 
                agriculture, education, the economy, the family and 
                society, and assisting them to develop and implement 
                programs corresponding to these needs;
                    (E) promoting healthy lifestyles, including 
                abstinence, delaying sexual debut, monogamy, marriage, 
                faithfulness, use of condoms, and avoiding substance 
                abuse; and
                    (F) encouraging active involvement of the private 
                sector, including businesses, pharmaceutical and 
                biotechnology companies, the medical and scientific 
                communities, charitable foundations, private and 
                voluntary organizations and nongovernmental 
                organizations, faith-based organizations, community-
                based organizations, and other nonprofit entities.
            (23) Prostitution and other sexual victimization are 
        degrading to women and children and it should be the policy of 
        the United States to eradicate such practices. The sex 
        industry, the trafficking of individuals into such industry, 
        and sexual violence are additional causes of and factors in the 
        spread of the HIV/AIDS epidemic. One in nine South Africans is 
        living with AIDS, and sexual assault is rampant, at a 
        victimization rate of one in three women. Meanwhile in 
        Cambodia, as many as 40 percent of prostitutes are infected 
        with HIV and the country has the highest rate of increase of 
        HIV infection in all of Southeast Asia. Victims of coercive 
        sexual encounters do not get to make choices about their sexual 
        activities.
            (24) Strong coordination must exist among the various 
        agencies of the United States to ensure effective and efficient 
        use of financial and technical resources within the United 
        States Government with respect to the provision of 
        international HIV/AIDS assistance.
            (25) In his address to Congress on January 28, 2003, the 
        President announced the Administration's intention to embark on 
        a five-year emergency plan for AIDS relief, to confront HIV/
        AIDS with the goals of preventing 7,000,000 new HIV/AIDS 
        infections, treating at least 2,000,000 people with life-
        extending drugs, and providing humane care for millions of 
        people suffering from HIV/AIDS, and for children orphaned by 
        HIV/AIDS.
            (26) In this address to Congress, the President stated the 
        following: ``Today, on the continent of Africa, nearly 
        30,000,000 people have the AIDS virus--including 3,000,000 
        children under the age of 15. There are whole countries in 
        Africa where more than one-third of the adult population 
        carries the infection. More than 4,000,000 require immediate 
        drug treatment. Yet across that continent, only 50,000 AIDS 
        victims--only 50,000--are receiving the medicine they need.''.
            (27) Furthermore, the President focused on care and 
        treatment of HIV/AIDS in his address to Congress, stating the 
        following: ``Because the AIDS diagnosis is considered a death 
        sentence, many do not seek treatment. Almost all who do are 
        turned away. A doctor in rural South Africa describes his 
        frustration. He says, `We have no medicines. Many hospitals 
tell people, you've got AIDS, we can't help you. Go home and die.' In 
an age of miraculous medicines, no person should have to hear those 
words. AIDS can be prevented. Anti-retroviral drugs can extend life for 
many years ... Ladies and gentlemen, seldom has history offered a 
greater opportunity to do so much for so many.''.
            (28) Finally, the President stated that ``[w]e have 
        confronted, and will continue to confront, HIV/AIDS in our own 
        country'', proposing now that the United States should lead the 
        world in sparing innocent people from a plague of nature, and 
        asking Congress ``to commit $15,000,000,000 over the next five 
        years, including nearly $10,000,000,000 in new money, to turn 
        the tide against AIDS in the most afflicted nations of Africa 
        and the Caribbean''.

SEC. 3. DEFINITIONS.

    In this Act:
            (1) AIDS.--The term ``AIDS'' means the acquired immune 
        deficiency syndrome.
            (2) Appropriate congressional committees.--The term 
        ``appropriate congressional committees'' means the Committee on 
        Foreign Relations of the Senate and the Committee on 
        International Relations of the House of Representatives.
            (3) Global fund.--The term ``Global Fund'' means the 
        public-private partnership known as the Global Fund to Fight 
        AIDS, Tuberculosis and Malaria established pursuant to Article 
        80 of the Swiss Civil Code.
            (4) HIV.--The term ``HIV'' means the human immunodeficiency 
        virus, the pathogen that causes AIDS.
            (5) HIV/AIDS.--The term ``HIV/AIDS'' means, with respect to 
        an individual, an individual who is infected with HIV or living 
        with AIDS.
            (6) Relevant executive branch agencies.--The term 
        ``relevant executive branch agencies'' means the Department of 
        State, the United States Agency for International Development, 
        and any other department or agency of the United States that 
        participates in international HIV/AIDS activities pursuant to 
        the authorities of such department or agency or the Foreign 
        Assistance Act of 1961.

SEC. 4. PURPOSE.

    The purpose of this Act is to strengthen United States leadership 
and the effectiveness of the United States response to certain global 
infectious diseases by--
            (1) establishing a comprehensive, integrated five-year, 
        global strategy to fight HIV/AIDS that encompasses a plan for 
        phased expansion of critical programs and improved coordination 
        among relevant executive branch agencies and between the United 
        States and foreign governments and international organizations;
            (2) providing increased resources for multilateral efforts 
        to fight HIV/AIDS;
            (3) providing increased resources for United States 
        bilateral efforts, particularly for technical assistance and 
        training, to combat HIV/AIDS, tuberculosis, and malaria;
            (4) encouraging the expansion of private sector efforts and 
        expanding public-private sector partnerships to combat HIV/
        AIDS; and
            (5) intensifying efforts to support the development of 
        vaccines and treatment for HIV/AIDS, tuberculosis, and malaria.

SEC. 5. AUTHORITY TO CONSOLIDATE AND COMBINE REPORTS.

    With respect to the reports required by this Act to be submitted by 
the President, to ensure an efficient use of resources, the President 
may, in his discretion and notwithstanding any other provision of this 
Act, consolidate or combine any of these reports, except for the report 
required by section 101 of this Act, so long as the required elements 
of each report are addressed and reported within a 90-day period from 
the original deadline date for submission of the report specified in 
this Act. The President may also enter into contracts with 
organizations with relevant expertise to develop, originate, or 
contribute to any of the reports required by this Act to be submitted 
by the President.

               TITLE I--POLICY PLANNING AND COORDINATION

SEC. 101. DEVELOPMENT OF A COMPREHENSIVE, FIVE-YEAR, GLOBAL STRATEGY.

    (a) Strategy.--The President shall establish a comprehensive, 
integrated, five-year strategy to combat global HIV/AIDS that 
strengthens the capacity of the United States to be an effective leader 
of the international campaign against HIV/AIDS. Such strategy shall 
maintain sufficient flexibility and remain responsive to the ever-
changing nature of the HIV/AIDS pandemic and shall--
            (1) include specific objectives, multisectoral approaches, 
        and specific strategies to treat individuals infected with HIV/
        AIDS and to prevent the further spread of HIV infections, with 
        a particular focus on the needs of families with children 
        (including the prevention of mother-to-child transmission), 
        women, young people, and children (such as unaccompanied minor 
        children and orphans);
            (2) as part of the strategy, implement a tiered approach to 
        direct delivery of care and treatment through a system based on 
        central facilities augmented by expanding circles of local 
        delivery of care and treatment through local systems and 
        capacity;
            (3) assign priorities for relevant executive branch 
        agencies;
            (4) provide that the reduction of HIV/AIDS behavioral risks 
        shall be a priority of all prevention efforts in terms of 
        funding, educational messages, and activities by promoting 
        abstinence from sexual activity and substance abuse, 
        encouraging monogamy and faithfulness, promoting the effective 
        use of condoms, and eradicating prostitution, the sex trade, 
        rape, sexual assault and sexual exploitation of women and 
        children;
            (5) improve coordination among relevant executive branch 
        agencies, foreign governments, and international organizations;
            (6) project general levels of resources needed to achieve 
        the stated objectives;
            (7) expand public-private partnerships and the leveraging 
        of resources; and
            (8) maximize United States capabilities in the areas of 
        technical assistance and training and research, including 
        vaccine research.
    (b) Report.--
            (1) In general.--Not later than 270 days after the date of 
        enactment of this Act, the President shall submit to the 
        appropriate congressional committees a report setting forth the 
        strategy described in subsection (a).
            (2) Report contents.--The report required by paragraph (1) 
        shall include a discussion of the elements described in 
        paragraph (3) and may include a discussion of additional 
        elements relevant to the strategy described in subsection (a). 
        Such discussion may include an explanation as to why a 
        particular element described in paragraph (3) is not relevant 
        to such strategy.
            (3) Report elements.--The elements referred to in paragraph 
        (2) are the following:
                    (A) The objectives, general and specific, of the 
                strategy.
                    (B) A description of the criteria for determining 
                success of the strategy.
                    (C) A description of the manner in which the 
                strategy will address the fundamental elements of 
                prevention and education, care, and treatment 
                (including increasing access to pharmaceuticals and to 
                vaccines), the promotion of abstinence, monogamy, 
                avoidance of substance abuse, and use of condoms, 
                research (including incentives for vaccine development 
                and new protocols), training of health care workers, 
                the development of health care infrastructure and 
                delivery systems, and avoidance of substance abuse.
                    (D) A description of the manner in which the 
                strategy will promote the development and 
                implementation of national and community-based 
                multisectoral strategies and programs, including those 
                designed to enhance leadership capacity particularly at 
                the community level.
                    (E) A description of the specific strategies 
                developed to meet the unique needs of women, including 
                the empowerment of women in interpersonal situations, 
                young people and children, including those orphaned by 
                HIV/AIDS and those who are victims of the sex trade, 
                rape, sexual abuse, assault, and exploitation.
                    (F) A description of the programs to be undertaken 
                to maximize United States contributions in the areas of 
                technical assistance, training (particularly of health 
                care workers and community-based leaders in affected 
                sectors), and research, including the promotion of 
                research on vaccines and microbicides.
                    (G) An identification of the relevant executive 
                branch agencies that will be involved and the 
                assignment of priorities to those agencies.
                    (H) A description of the role of each relevant 
                executive branch agency and the types of programs that 
                the agency will be undertaking.
                    (I) A description of the mechanisms that will be 
                utilized to coordinate the efforts of the relevant 
                executive branch agencies, to avoid duplication of 
                efforts, to enhance on-site coordination efforts, and 
                to ensure that each agency undertakes programs 
                primarily in those areas where the agency has the 
                greatest expertise, technical capabilities, and 
                potential for success.
                    (J) A description of the mechanisms that will be 
                utilized to ensure greater coordination between the 
                United States and foreign governments and international 
                organizations including the Global Fund, UNAIDS, 
                international financial institutions, and private 
                sector organizations.
                    (K) The level of resources that will be needed on 
                an annual basis and the manner in which those resources 
                would generally be allocated among the relevant 
                executive branch agencies.
                    (L) A description of the mechanisms to be 
                established for monitoring and evaluating programs, 
                promoting successful models, and for terminating 
                unsuccessful programs.
                    (M) A description of the manner in which private, 
                nongovernmental entities will factor into the United 
                States Government-led effort and a description of the 
                type of partnerships that will be created to maximize 
                the capabilities of these private sector entities and 
                to leverage resources.
                    (N) A description of the ways in which United 
                States leadership will be used to enhance the overall 
                international response to the HIV/AIDS pandemic and 
                particularly to heighten the engagement of the member 
                states of the G-8 and to strengthen key financial and 
                coordination mechanisms such as the Global Fund and 
                UNAIDS.
                    (O) A description of the manner in which the United 
                States strategy for combating HIV/AIDS relates to and 
                supports other United States assistance strategies in 
                developing countries.
                    (P) A description of the programs to be carried out 
                under the strategy that are specifically targeted at 
                women and girls to educate them about the spread of 
                HIV/AIDS.
                    (Q) A description of efforts being made to address 
                the unique needs of families with children with respect 
                to HIV/AIDS, including efforts to preserve the family 
                unit.
                    (R) An analysis of the emigration of critically 
                important medical and public health personnel, 
                including physicians, nurses, and supervisors from sub-
                Saharan African countries that are acutely impacted by 
                HIV/AIDS, including a description of the causes, 
                effects, and the impact on the stability of health 
                infrastructures, as well as a summary of incentives and 
                programs that the United States could provide, in 
                concert with other private and public sector partners 
                and international organizations, to stabilize health 
                institutions by encouraging critical personnel to 
                remain in their home countries.
                    (S) A description of the specific strategies 
                developed to promote sustainability of HIV/AIDS 
                pharmaceuticals (including antiretrovirals) and the 
                effects of drug resistance on HIV/AIDS patients.
                    (T) A description of the specific strategies to 
                ensure that the extraordinary benefit of HIV/AIDS 
                pharmaceuticals (especially antiretrovirals) are not 
                diminished through the illegal counterfeiting of 
                pharmaceuticals and black market sales of such 
                pharmaceuticals.
                    (U) An analysis of the prevalence of Human 
                Papilloma Virus (HPV) in sub-Saharan Africa and the 
                impact that condom usage has upon the spread of HPV in 
                sub-Saharan Africa.

SEC. 102. HIV/AIDS RESPONSE COORDINATOR.

    (a) Establishment of Position.--Section 1 of the State Department 
Basic Authorities Act of 1956 (22 U.S.C. 265(a)) is amended--
            (1) by redesignating subsection (f) as subsection (g); and
            (2) by inserting after subsection (e) the following:
    ``(f) HIV/AIDS Response Coordinator.--
            ``(1) In general.--There shall be established within the 
        Department of State in the immediate office of the Secretary of 
        State a Coordinator of United States Government Activities to 
        Combat HIV/AIDS Globally, who shall be appointed by the 
President, by and with the advice and consent of the Senate. The 
Coordinator shall report directly to the Secretary.
            ``(2) Authorities and duties; definitions.--
                    ``(A) Authorities.--The Coordinator, acting through 
                such nongovernmental organizations (including faith-
                based and community-based organizations) and relevant 
                executive branch agencies as may be necessary and 
                appropriate to effect the purposes of this section, is 
                authorized--
                            ``(i) to operate internationally to carry 
                        out prevention, care, treatment, support, 
                        capacity development, and other activities for 
                        combatting HIV/AIDS;
                            ``(ii) to transfer and allocate funds to 
                        relevant executive branch agencies; and
                            ``(iii) to provide grants to, and enter 
                        into contracts with, nongovernmental 
                        organizations (including faith-based and 
                        community-based organizations) to carry out the 
                        purposes of section.
                    ``(B) Duties.--
                            ``(i) In general.--The Coordinator shall 
                        have primary responsibility for the oversight 
                        and coordination of all resources and 
                        international activities of the United States 
                        Government to combat the HIV/AIDS pandemic, 
                        including all programs, projects, and 
                        activities of the United States Government 
                        relating to the HIV/AIDS pandemic under the 
                        United States Leadership Against HIV/AIDS, 
                        Tuberculosis, and Malaria Act of 2003 or any 
                        amendment made by that Act.
                            ``(ii) Specific duties.--The duties of the 
                        Coordinator shall specifically include the 
                        following:
                                    ``(I) Ensuring program and policy 
                                coordination among the relevant 
                                executive branch agencies and 
                                nongovernmental organizations, 
                                including auditing, monitoring, and 
                                evaluation of all such programs.
                                    ``(II) Ensuring that each relevant 
                                executive branch agency undertakes 
                                programs primarily in those areas where 
                                the agency has the greatest expertise, 
                                technical capabilities, and potential 
                                for success.
                                    ``(III) Avoiding duplication of 
                                effort.
                                    ``(IV) Ensuring coordination of 
                                relevant executive branch agency 
                                activities in the field.
                                    ``(V) Pursuing coordination with 
                                other countries and international 
                                organizations.
                                    ``(VI) Resolving policy, program, 
                                and funding disputes among the relevant 
                                executive branch agencies.
                                    ``(VII) Directly approving all 
                                activities of the United States 
                                (including funding) relating to 
                                combatting HIV/AIDS in each of 
                                Botswana, Cote d'Ivoire, Ethiopia, 
                                Guyana, Haiti, Kenya, Mozambique, 
                                Namibia, Nigeria, Rwanda, South Africa, 
                                Tanzania, Uganda, Zambia, and other 
                                countries designated by the President, 
                                which other designated countries may 
                                include those countries in which the 
                                United States is implementing HIV/AIDS 
                                programs as of the date of the 
                                enactment of the United States 
                                Leadership Against HIV/AIDS, 
                                Tuberculosis, and Malaria Act of 2003.
                                    ``(VIII) Establishing due diligence 
                                criteria for all recipients of funds 
                                section and all activities subject to 
                                the coordination and appropriate 
                                monitoring, evaluation, and audits 
                                carried out by the Coordinator 
                                necessary to assess the measurable 
                                outcomes of such activities.
                    ``(C) Definitions.--In this paragraph:
                            ``(i) AIDS.--The term `AIDS' means acquired 
                        immune deficiency syndrome.
                            ``(ii) HIV.--The term `HIV' means the human 
                        immunodeficiency virus, the pathogen that 
                        causes AIDS.
                            ``(iii) HIV/AIDS.--The term `HIV/AIDS' 
                        means, with respect to an individual, an 
                        individual who is infected with HIV or living 
                        with AIDS.
                            ``(iv) Relevant executive branch 
                        agencies.--The term `relevant executive branch 
                        agencies' means the Department of State, the 
                        United States Agency for International 
                        Development, the Department of Health and Human 
                        Services (including the Public Health Service), 
                        and any other department or agency of the 
                        United States that participates in 
                        international HIV/AIDS activities pursuant to 
                        the authorities of such department or agency or 
                        this Act.''.
    (b) Resources.--Not later than 90 days after the date of enactment 
of this Act, the President shall specify the necessary financial and 
personnel resources, from funds appropriated pursuant to the 
authorization of appropriations under section 401 for HIV/AIDS 
assistance, that shall be assigned to and under the direct control of 
the Coordinator of United States Government Activities to Combat HIV/
AIDS Globally to establish and maintain the duties and supporting 
activities assigned to the Coordinator by this Act and the amendments 
made by this Act.
    (c) Establishment of Separate Account.--There is established in the 
general fund of the Treasury a separate account which shall be known as 
the ``Activities to Combat HIV/AIDS Globally Fund'' and which shall be 
administered by the Coordinator of United States Government Activities 
to Combat HIV/AIDS Globally. There shall be deposited into the Fund all 
amounts appropriated pursuant to the authorization of appropriations 
under section 401 for HIV/AIDS assistance, except for amounts 
appropriated for United States contributions to the Global Fund.

TITLE II--SUPPORT FOR MULTILATERAL FUNDS, PROGRAMS, AND PUBLIC-PRIVATE 
                              PARTNERSHIPS

SEC. 201. SENSE OF CONGRESS ON PUBLIC-PRIVATE PARTNERSHIPS.

    (a) Findings.--Congress makes the following findings:
            (1) Innovative partnerships between governments and 
        organizations in the private sector (including foundations, 
        universities, corporations, faith-based and community-based 
        organizations, and other nongovernmental organizations) have 
        proliferated in recent years, particularly in the area of 
        health.
            (2) Public-private sector partnerships multiply local and 
        international capacities to strengthen the delivery of health 
        services in developing countries and to accelerate research for 
        vaccines and other pharmaceutical products that are essential 
        to combat infectious diseases decimating the populations of 
        these countries.
            (3) These partnerships maximize the unique capabilities of 
        each sector while combining financial and other resources, 
        scientific knowledge, and expertise toward common goals which 
        neither the public nor the private sector can achieve alone.
            (4) Sustaining existing public-private partnerships and 
        building new ones are critical to the success of the 
        international community's efforts to combat HIV/AIDS and other 
        infectious diseases around the globe.
    (b) Sense of Congress.--It is the sense of Congress that--
            (1) the sustainment and promotion of public-private 
        partnerships should be a priority element of the strategy 
        pursued by the United States to combat the HIV/AIDS pandemic 
        and other global health crises; and
            (2) the United States should systematically track the 
        evolution of these partnerships and work with others in the 
        public and private sector to profile and build upon those 
        models that are most effective.

SEC. 202. PARTICIPATION IN THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS 
              AND MALARIA.

    (a) Authority for United States Participation.--
            (1) United states participation.--The United States is 
        hereby authorized to participate in the Global Fund.
            (2) Privileges and immunities.--The Global Fund shall be 
        considered a public international organization for purposes of 
        section 1 of the International Organizations Immunities Act (22 
        U.S.C. 288).
    (b) Reports to Congress.--Not later than 1 year after the date of 
the enactment of this Act, and annually thereafter for the duration of 
the Global Fund, the President shall submit to the appropriate 
congressional committees a report on the Global Fund, including 
contributions pledged to, contributions (including donations from the 
private sector) received by, and projects funded by the Global Fund, 
and the mechanisms established for transparency and accountability in 
the grant-making process.
    (c) United States Financial Participation.--
            (1) Authorization of appropriations.--In addition to any 
        other funds authorized to be appropriated for bilateral or 
        multilateral HIV/AIDS, tuberculosis, or malaria programs, of 
        the amounts authorized to be appropriated under section 401, 
        there are authorized to be appropriated to the President up to 
        $1,000,000,000 in the fiscal year 2004, and such sums as may be 
        necessary for the fiscal years 2005-2008, for contributions to 
        the Global Fund.
            (2) Availability of funds.--Amounts appropriated under 
        paragraph (1) are authorized to remain available until 
        expended.
            (3) Reprogramming of fiscal year 2001 funds.--Funds made 
        available for fiscal year 2001 under section 141 of the Global 
        AIDS and Tuberculosis Relief Act of 2000--
                    (A) are authorized to remain available until 
                expended; and
                    (B) shall be transferred to, merged with, and made 
                available for the same purposes as, funds made 
                available for fiscal years 2004 through 2008 under 
                paragraph (1).
            (4) Limitation.--
                    (A)(i) At any time during fiscal years 2004 through 
                2008, no United States contribution to the Global Fund 
                may cause the total amount of United States Government 
                contributions to the Global Fund to exceed 33 percent 
                of the total amount of funds contributed to the Global 
                Fund from all other sources. Contributions to the 
                Global Fund from the International Bank for 
                Reconstruction and Development and the International 
                Monetary Fund shall not be considered in determining 
                compliance with this paragraph.
                    (ii) If, at any time during any of the fiscal years 
                2004 through 2008, the President determines that the 
                Global Fund has provided assistance to a country, the 
                government of which the Secretary of State has 
                determined, for purposes of section 6(j)(1) of the 
                Export Administration Act of 1979 (50 U.S.C. App. 
                2405(j)(1)), has repeatedly provided support for acts 
                of international terrorism, then the United States 
                shall withhold from its contribution for the next 
                fiscal year an amount equal to the amount expended by 
                the Fund to the government of each such country.
                    (B) Any amount made available under this subsection 
                that is withheld by reason of subparagraph (A) shall be 
                contributed to the Global Fund as soon as practicable, 
                subject to subparagraph (A), after additional 
                contributions to the Global Fund are made from other 
                sources.
                    (C)(i) The President may suspend the application of 
                subparagraph (A) with respect to a fiscal year if the 
                President determines that an international health 
                emergency threatens the national security interests of 
                the United States.
                    (ii) The President shall notify the Committee on 
                International Relations of the House of Representatives 
                and the Committee on Foreign Relations of the Senate 
                not less than 5 days before making a determination 
                under clause (i) with respect to the application of 
                subparagraph (A)(i) and shall include in the 
                notification--
                            (I) a justification as to why increased 
                        United States Government contributions to the 
                        Global Fund is preferable to increased United 
                        States assistance to combat HIV/AIDS, 
                        tuberculosis, and malaria on a bilateral basis; 
                        and
                            (II) an explanation as to why other 
                        government donors to the Global Fund are unable 
                        to provide adequate contributions to the Fund.
    (d) Interagency Technical Review Panel.--
            (1) Establishment.--The Coordinator of United States 
        Government Activities to Combat HIV/AIDS Globally, established 
        in section 1(f)(1) of the State Department Basic Authorities 
        Act of 1956 (as added by section 102(a) of this Act), shall 
        establish in the executive branch an interagency technical 
        review panel.
            (2) Duties.--The interagency technical review panel shall 
        serve as a ``shadow'' panel to the Global Fund by--
                    (A) periodically reviewing all proposals received 
                by the Global Fund; and
                    (B) providing guidance to the United States persons 
                who are representatives on the panels, committees, and 
                boards of the Global Fund, on the technical efficacy, 
                suitability, and appropriateness of the proposals, and 
                ensuring that such persons are fully informed of 
                technical inadequacies or other aspects of the 
                proposals that are inconsistent with the purposes of 
                this or any other Act relating to the provision of 
                foreign assistance in the area of AIDS.
            (3) Membership.--The interagency technical review panel 
        shall consist of qualified medical and development experts who 
        are officers or employees of the Department of Health and Human 
        Services, the Department of State, and the United States Agency 
        for International Development.
            (4) Chair.--The Coordinator referred to in paragraph (1) 
        shall chair the interagency technical review panel.
    (e) Monitoring by Comptroller General.--
            (1) Monitoring.--The Comptroller General shall monitor and 
        evaluate projects funded by the Global Fund.
            (2) Report.--The Comptroller General shall on a biennial 
        basis shall prepare and submit to the appropriate congressional 
        committees a report that contains the results of the monitoring 
        and evaluation described in paragraph (1) for the preceding 2-
        year period.

SEC. 203. VOLUNTARY CONTRIBUTIONS TO INTERNATIONAL VACCINE FUNDS.

    (a) Vaccine Fund.--Section 302(k) of the Foreign Assistance Act of 
1961 (22 U.S.C. 2222(k)) is amended--
            (1) by striking ``$50,000,000 for each of the fiscal years 
        2001 and 2002'' and inserting ``such sums as may be necessary 
        for each of the fiscal years 2004 through 2008''; and
            (2) by striking ``Global Alliance for Vaccines and 
        Immunizations'' and inserting ``Vaccine Fund''.
    (b) International AIDS Vaccine Initiative.--Section 302(l) of the 
Foreign Assistance Act of 1961 (22 U.S.C. 2222(l)) is amended by 
striking ``$10,000,000 for each of the fiscal years 2001 and 2002'' and 
inserting ``such sums as may be necessary for each of the fiscal years 
2004 through 2008''.
    (c) Support for the Development of Malaria Vaccine.--Section 302 of 
the Foreign Assistance Act of 1961 (22 U.S.C. 2222)) is amended by 
adding at the end the following new subsection:
    ``(m) In addition to amounts otherwise available under this 
section, there are authorized to be appropriated to the President such 
sums as may be necessary for each of the fiscal years 2004 through 2008 
to be available for United States contributions to malaria vaccine 
development programs, including the Malaria Vaccine Initiative of the 
Program for Appropriate Technologies in Health (PATH).''.

                      TITLE III--BILATERAL EFFORTS

              Subtitle A--General Assistance and Programs

SEC. 301. ASSISTANCE TO COMBAT HIV/AIDS.

    (a) Amendment of the Foreign Assistance Act of 1961.--Chapter 1 of 
part I of the Foreign Assistance Act of 1961 (22 U.S.C. 2151 et seq.) 
is amended--
            (1) in section 104(c) (22 U.S.C. 2151b(c)), by striking 
        paragraphs (4) through (7); and
            (2) by inserting after section 104 the following new 
        section:

``SEC. 104A. ASSISTANCE TO COMBAT HIV/AIDS.

    ``(a) Finding.--Congress recognizes that the alarming spread of 
HIV/AIDS in countries in sub-Saharan Africa, the Caribbean, and other 
developing countries is a major global health, national security, 
development, and humanitarian crisis.
    ``(b) Policy.--It is a major objective of the foreign assistance 
program of the United States to provide assistance for the prevention, 
treatment, and control of HIV/AIDS. The United States and other 
developed countries should provide assistance to countries in sub-
Saharan Africa, the Caribbean, and other countries and areas to control 
this crisis through HIV/AIDS prevention, treatment, monitoring, and 
related activities, particularly activities focused on women and youth, 
including strategies to protect women and prevent mother-to-child 
transmission of the HIV infection.
    ``(c) Authorization.--
            ``(1) In general.--Consistent with section 104(c), the 
        President is authorized to furnish assistance, on such terms 
        and conditions as the President may determine, for HIV/AIDS, 
        including to prevent, treat, and monitor HIV/AIDS, and carry 
        out related activities, in countries in sub-Saharan Africa, the 
        Caribbean, and other countries and areas.
            ``(2) Role of ngos.--It is the sense of Congress that the 
        President should provide an appropriate level of assistance 
        under paragraph (1) through nongovernmental organizations 
        (including faith-based and community-based organizations) in 
        countries in sub-Saharan Africa, the Caribbean, and other 
        countries and areas affected by the HIV/AIDS pandemic.
            ``(3) Coordination of assistance efforts.--The President 
        shall coordinate the provision of assistance under paragraph 
        (1) with the provision of related assistance by the Joint 
        United Nations Programme on HIV/AIDS (UNAIDS), the United 
        Nations Children's Fund (UNICEF), the World Health Organization 
        (WHO), the United Nations Development Programme (UNDP), the 
        Global Fund to Fight AIDS, Tuberculosis and Malaria and other 
        appropriate international organizations (such as the 
        International Bank for Reconstruction and Development), 
        relevant regional multilateral development institutions, 
        national, state, and local governments of foreign countries, 
        appropriate governmental and nongovernmental organizations, and 
        relevant executive branch agencies.
    ``(d) Activities Supported.--Assistance provided under subsection 
(c) shall, to the maximum extent practicable, be used to carry out the 
following activities:
            ``(1) Prevention.--Prevention of HIV/AIDS through 
        activities including--
                    ``(A) programs and efforts that are designed or 
                intended to impart knowledge with the exclusive purpose 
                of helping individuals avoid behaviors that place them 
                at risk of HIV infection, including integration of such 
                programs into health programs and the inclusion in 
                counseling programs of information on methods of 
                avoiding infection of HIV, including delaying sexual 
                debut, abstinence, fidelity and monogamy, reduction of 
                casual sexual partnering, and where appropriate, use of 
                condoms;
                    ``(B) assistance to establish and implement 
                culturally appropriate HIV/AIDS education and 
                prevention programs that focus on helping individuals 
                avoid infection of HIV/AIDS, implemented through 
                nongovernmental organizations, including faith-based 
                and community-based organizations, particularly those 
                organizations that utilize both professionals and 
                volunteers with appropriate skills, experience, and 
                community presence;
                    ``(C) assistance for the purpose of providing 
                voluntary testing and counseling (including the 
                incorporation of confidentiality protections with 
                respect to such testing and counseling);
                    ``(D) assistance for the purpose of preventing 
                mother-to-child transmission of the HIV infection, 
                including medications to prevent such transmission and 
                access to infant formula and other alternatives for 
                infant feeding;
                    ``(E) assistance to ensure a safe blood supply and 
                sterile medical equipment; and
                    ``(F) assistance to help avoid substance abuse and 
                intravenous drug use that can lead to HIV infection.
            ``(2) Treatment.--The treatment and care of individuals 
        with HIV/AIDS, including--
                    ``(A) assistance to establish and implement 
                programs to strengthen and broaden indigenous health 
                care delivery systems and the capacity of such systems 
                to deliver HIV/AIDS pharmaceuticals and otherwise 
                provide for the treatment of individuals with HIV/AIDS, 
                including clinical training for indigenous 
                organizations and health care providers;
                    ``(B) assistance to strengthen and expand hospice 
                and palliative care programs to assist patients 
                debilitated by HIV/AIDS, their families, and the 
                primary caregivers of such patients, including programs 
                that utilize faith-based and community-based 
                organizations; and
                    ``(C) assistance for the purpose of the care and 
                treatment of individuals with HIV/AIDS through the 
                provision of pharmaceuticals, including antiretrovirals 
                and other pharmaceuticals and therapies for the 
                treatment of opportunistic infections, nutritional 
                support, and other treatment modalities.
            ``(3) Preventative intervention education and 
        technologies.--(A) With particular emphasis on specific 
        populations that represent a particularly high risk of 
        contracting or spreading HIV/AIDS, including those exploited 
        through the sex trade, victims of rape and sexual assault, 
        individuals already infected with HIV/AIDS, and in cases of 
        occupational exposure of health care workers, assistance with 
        efforts to reduce the risk of HIV/AIDS infection including 
        post-exposure pharmaceutical prophylaxis, and necessary 
        pharmaceuticals and commodities, including test kits, condoms, 
        and, when proven effective, microbicides.
            ``(B) Bulk purchases of available test kits, condoms, and, 
        when proven effective, microbicides that are intended to reduce 
        the risk of HIV/AIDS transmission and for appropriate program 
support for the introduction and distribution of these commodities, as 
well as education and training on the use of the technologies.
            ``(4) Monitoring.--The monitoring of programs, projects, 
        and activities carried out pursuant to paragraphs (1) through 
        (3), including--
                    ``(A) monitoring to ensure that adequate controls 
                are established and implemented to provide HIV/AIDS 
                pharmaceuticals and other appropriate medicines to poor 
                individuals with HIV/AIDS;
                    ``(B) appropriate evaluation and surveillance 
                activities;
                    ``(C) monitoring to ensure that appropriate 
                measures are being taken to maintain the sustainability 
                of HIV/AIDS pharmaceuticals (especially 
                antiretrovirals) and ensure that drug resistance is not 
                compromising the benefits of such pharmaceuticals; and
                    ``(D) monitoring to ensure appropriate law 
                enforcement officials are working to ensure that HIV/
                AIDS pharmaceuticals are not diminished through illegal 
                counterfeiting or black market sales of such 
                pharmaceuticals.
            ``(5) Pharmaceuticals.--
                    ``(A) Procurement.--The procurement of HIV/AIDS 
                pharmaceuticals, antiviral therapies, and other 
                appropriate medicines, including medicines to treat 
                opportunistic infections.
                    ``(B) Mechanisms for quality control and 
                sustainable supply.--Mechanisms to ensure that such 
                HIV/AIDS pharmaceuticals, antiretroviral therapies, and 
                other appropriate medicines are quality-controlled and 
                sustainably supplied.
                    ``(C) Distribution.--The distribution of such HIV/
                AIDS pharmaceuticals, antiviral therapies, and other 
                appropriate medicines (including medicines to treat 
                opportunistic infections) to qualified national, 
                regional, or local organizations for the treatment of 
                individuals with HIV/AIDS in accordance with 
                appropriate HIV/AIDS testing and monitoring 
                requirements and treatment protocols and for the 
                prevention of mother-to-child transmission of the HIV 
                infection.
            ``(6) Related activities.--The conduct of related 
        activities, including--
                    ``(A) the care and support of children who are 
                orphaned by the HIV/AIDS pandemic, including services 
                designed to care for orphaned children in a family 
                environment which rely on extended family members;
                    ``(B) improved infrastructure and institutional 
                capacity to develop and manage education, prevention, 
                and treatment programs, including training and the 
                resources to collect and maintain accurate HIV 
                surveillance data to target programs and measure the 
                effectiveness of interventions; and
                    ``(C) vaccine research and development partnership 
                programs with specific plans of action to develop a 
                safe, effective, accessible, preventive HIV vaccine for 
                use throughout the world.
            ``(7) Comprehensive hiv/aids public-private partnerships.--
        The establishment and operation of public-private partnership 
        entities within countries in sub-Saharan Africa, the Caribbean, 
        and other countries affected by the HIV/AIDS pandemic that are 
        dedicated to supporting the national strategy of such countries 
        regarding the prevention, treatment, and monitoring of HIV/
        AIDS. Each such public-private partnership should--
                    ``(A) support the development, implementation, and 
                management of comprehensive HIV/AIDS plans in support 
                of the national HIV/AIDS strategy;
                    ``(B) operate at all times in a manner that 
                emphasizes efficiency, accountability, and results-
                driven programs;
                    ``(C) engage both local and foreign development 
                partners and donors, including businesses, government 
                agencies, academic institutions, nongovernmental 
                organizations, foundations, multilateral development 
                agencies, and faith-based organizations, to assist the 
                country in coordinating and implementing HIV/AIDS 
                prevention, treatment, and monitoring programs in 
                accordance with its national HIV/AIDS strategy;
                    ``(D) provide technical assistance, consultant 
                services, financial planning, monitoring and 
                evaluation, and research in support of the national 
                HIV/AIDS strategy; and
                    ``(E) establish local human resource capacities for 
                the national HIV/AIDS strategy through the transfer of 
                medical, managerial, leadership, and technical skills.
    ``(e) Annual Report.--
            ``(1) In general.--Not later than January 31 of each year, 
        the President shall submit to the Committee on Foreign 
        Relations of the Senate and the Committee on International 
        Relations of the House of Representatives a report on the 
        implementation of this section for the prior fiscal year.
            ``(2) Report elements.--Each report shall include--
                    ``(A) a description of efforts made by each 
                relevant executive branch agency to implement the 
                policies set forth in this section, section 104B, and 
                section 104C;
                    ``(B) a description of the programs established 
                pursuant to such sections; and
                    ``(C) a detailed assessment of the impact of 
                programs established pursuant to such sections, 
                including--
                            ``(i)(I) the effectiveness of such programs 
                        in reducing the spread of the HIV infection, 
                        particularly in women and girls, in reducing 
                        mother-to-child transmission of the HIV 
                        infection, and in reducing mortality rates from 
                        HIV/AIDS; and
                            ``(II) the number of patients currently 
                        receiving treatment for AIDS in each country 
                        that receives assistance under this Act.
                            ``(ii) the progress made toward improving 
                        health care delivery systems (including the 
                        training of adequate numbers of staff) and 
                        infrastructure to ensure increased access to 
                        care and treatment;
                            ``(iii) with respect to tuberculosis, the 
                        increase in the number of people treated and 
                        the increase in number of tuberculosis patients 
                        cured through each program, project, or 
                        activity receiving United States foreign 
                        assistance for tuberculosis control purposes; 
                        and
                            ``(iv) with respect to malaria, the 
                        increase in the number of people treated and 
                        the increase in number of malaria patients 
                        cured through each program, project, or 
                        activity receiving United States foreign 
                        assistance for malaria control purposes.
    ``(f) Funding Limitation.--Of the funds made available to carry out 
this section in any fiscal year, not more than 7 percent may be used 
for the administrative expenses of the United States Agency for 
International Development in support of activities described in section 
104(c), this section, section 104B, and section 104C. Such amount shall 
be in addition to other amounts otherwise available for such purposes.
    ``(g) Definitions.--In this section:
            ``(1) AIDS.--The term `AIDS' means acquired immune 
        deficiency syndrome.
            ``(2) HIV.--The term `HIV' means the human immunodeficiency 
        virus, the pathogen that causes AIDS.
            ``(3) HIV/AIDS.--The term `HIV/AIDS' means, with respect to 
        an individual, an individual who is infected with HIV or living 
        with AIDS.
            ``(4) Relevant executive branch agencies.--The term 
        `relevant executive branch agencies' means the Department of 
        State, the United States Agency for International Development, 
        the Department of Health and Human Services (including its 
        agencies and offices), and any other department or agency of 
        the United States that participates in international HIV/AIDS 
        activities pursuant to the authorities of such department or 
        agency or this Act.''.
    (b) Authorization of Appropriations.--
            (1) In general.--In addition to funds available under 
        section 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C. 
        2151b(c)) for such purpose or under any other provision of that 
        Act, there are authorized to be appropriated to the President, 
        from amounts authorized to be appropriated under section 401, 
        such sums as may be necessary for each of the fiscal years 2004 
        through 2008 to carry out section 104A of the Foreign 
        Assistance Act of 1961, as added by subsection (a).
            (2) Availability of funds.--Amounts appropriated pursuant 
        to paragraph (1) are authorized to remain available until 
        expended.
            (3) Allocation of Funds.--Of the amount authorized to be 
        appropriated by paragraph (1) for the fiscal years 2004 through 
        2008, such sums as may be necessary are authorized to be 
        appropriated to carry out section 104A(d)(4) of the Foreign 
        Assistance Act of 1961 (as added by subsection (a)), relating 
        to the procurement and distribution of HIV/AIDS 
        pharmaceuticals.
    (c) Relationship to Assistance Programs to Enhance Nutrition.--In 
recognition of the fact that malnutrition may hasten the progression of 
HIV to AIDS and may exacerbate the decline among AIDS patients leading 
to a shorter life span, the Administrator of the United States Agency 
for International Development shall, as appropriate--
            (1) integrate nutrition programs with HIV/AIDS activities, 
        generally;
            (2) provide, as a component of an anti-retroviral therapy 
        program, support for food and nutrition to individuals infected 
        with and affected by HIV/AIDS; and
            (3) provide support for food and nutrition for children 
        affected by HIV/AIDS and to communities and households caring 
        for children affected by HIV/AIDS.
    (d) Eligibility for Assistance.--An organization that is otherwise 
eligible to receive assistance under section 104A of the Foreign 
Assistance Act of 1961 (as added by subsection (a)) or under any other 
provision of this Act (or any amendment made by this Act) to prevent, 
treat, or monitor HIV/AIDS shall not be required, as a condition of 
receiving the assistance, to endorse or utilize a multisectoral 
approach to combatting HIV/AIDS.
    (e) Limitation.--No funds made available to carry out this Act, or 
any amendment made by this Act, may be used to promote or advocate the 
legalization or practice of prostitution or sex trafficking. Nothing in 
the preceding sentence shall be construed to preclude the provision to 
individuals of palliative care, treatment, or post-exposure 
pharmaceutical prophylaxis, and necessary pharmaceuticals and 
commodities, including test kits, condoms, and, when proven effective, 
microbicides.
    (f) Limitation.--No funds made available to carry out this Act, or 
any amendment made by this Act, may be used to provide assistance to 
any group or organization that does not have a policy explicitly 
opposing prostitution and sex trafficking.

SEC. 302. ASSISTANCE TO COMBAT TUBERCULOSIS.

    (a) Amendment of the Foreign Assistance Act of 1961.--Chapter 1 of 
part I of the Foreign Assistance Act of 1961 (22 U.S.C. 2151 et seq.), 
as amended by section 301 of this Act, is further amended by inserting 
after section 104A the following new section:

``SEC. 104B. ASSISTANCE TO COMBAT TUBERCULOSIS.

    ``(a) Findings.--Congress makes the following findings:
            ``(1) Congress recognizes the growing international problem 
        of tuberculosis and the impact its continued existence has on 
        those countries that had previously largely controlled the 
        disease.
            ``(2) Congress further recognizes that the means exist to 
        control and treat tuberculosis through expanded use of the DOTS 
        (Directly Observed Treatment Short-course) treatment strategy, 
        including DOTS-Plus to address multi-drug resistant 
        tuberculosis, and adequate investment in newly created 
        mechanisms to increase access to treatment, including the 
        Global Tuberculosis Drug Facility established in 2001 pursuant 
        to the Amsterdam Declaration to Stop TB and the Global Alliance 
        for TB Drug Development.
    ``(b) Policy.--It is a major objective of the foreign assistance 
program of the United States to control tuberculosis, including the 
detection of at least 70 percent of the cases of infectious 
tuberculosis, and the cure of at least 85 percent of the cases 
detected, not later than December 31, 2005, in those countries 
classified by the World Health Organization as among the highest 
tuberculosis burden, and not later than December 31, 2010, in all 
countries in which the United States Agency for International 
Development has established development programs.
    ``(c) Authorization.--To carry out this section and consistent with 
section 104(c), the President is authorized to furnish assistance, on 
such terms and conditions as the President may determine, for the 
prevention, treatment, control, and elimination of tuberculosis.
    ``(d) Coordination.--In carrying out this section, the President 
shall coordinate with the World Health Organization, the Global Fund to 
Fight AIDS, Tuberculosis, and Malaria, and other organizations with 
respect to the development and implementation of a comprehensive 
tuberculosis control program.
    ``(e) Priority to DOTS Coverage.--In furnishing assistance under 
subsection (c), the President shall give priority to activities that 
increase Directly Observed Treatment Short-course (DOTS) coverage and 
treatment of multi-drug resistant tuberculosis where needed using DOTS-
Plus, including funding for the Global Tuberculosis Drug Facility, the 
Stop Tuberculosis Partnership, and the Global Alliance for TB Drug 
Development. In order to meet the requirement of the preceding 
sentence, the President should ensure that not less than 75 percent of 
the amount made available to carry out this section for a fiscal year 
should be expended for antituberculosis drugs, supplies, direct patient 
services, and training in diagnosis and treatment for Directly Observed 
Treatment Short-course (DOTS) coverage and treatment of multi-drug 
resistant tuberculosis using DOTS-Plus, including substantially 
increased funding for the Global Tuberculosis Drug Facility.
    ``(f) Definitions.--In this section:
            ``(1) DOTS.--The term `DOTS' or `Directly Observed 
        Treatment Short-course' means the World Health Organization-
        recommended strategy for treating tuberculosis.
            ``(2) DOTS-plus.--The term `DOTS-Plus' means a 
        comprehensive tuberculosis management strategy that is built 
        upon and works as a supplement to the standard DOTS strategy, 
        and which takes into account specific issues (such as use of 
        second line anti-tuberculosis drugs) that need to be addressed 
        in areas where there is high prevalence of multi-drug resistant 
        tuberculosis.
            ``(3) Global alliance for tuberculosis drug development.--
        The term `Global Alliance for Tuberculosis Drug Development' 
        means the public-private partnership that brings together 
        leaders in health, science, philanthropy, and private industry 
        to devise new approaches to tuberculosis and to ensure that new 
        medications are available and affordable in high tuberculosis 
        burden countries and other affected countries.
            ``(4) Global tuberculosis drug facility.--The term `Global 
        Tuberculosis Drug Facility (GDF)' means the new initiative of 
        the Stop Tuberculosis Partnership to increase access to high-
        quality tuberculosis drugs to facilitate DOTS expansion.
            ``(5) Stop tuberculosis partnership.--The term `Stop 
        Tuberculosis Partnership' means the partnership of the World 
        Health Organization, donors including the United States, high 
        tuberculosis burden countries, multilateral agencies, and 
        nongovernmental and technical agencies committed to short- and 
        long-term measures required to control and eventually eliminate 
        tuberculosis as a public health problem in the world.''.
    (b) Authorization of Appropriations.--
            (1) In general.--In addition to funds available under 
        section 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C. 
        2151b(c)) for such purpose or under any other provision of that 
        Act, there are authorized to be appropriated to the President, 
        from amounts authorized to be appropriated under section 401, 
        such sums as may be necessary for each of the fiscal years 2004 
        through 2008 to carry out section 104B of the Foreign 
        Assistance Act of 1961, as added by subsection (a).
            (2) Availability of funds.--Amounts appropriated pursuant 
        to the authorization of appropriations under paragraph (1) are 
        authorized to remain available until expended.
            (3) Transfer of prior year funds.--Unobligated balances of 
        funds made available for fiscal year 2001, 2002, or 2003 under 
        section 104(c)(7) of the Foreign Assistance Act of 1961 (22 
        U.S.C. 2151b(c)(7) (as in effect immediately before the date of 
        enactment of this Act) shall be transferred to, merged with, 
        and made available for the same purposes as funds made 
        available for fiscal years 2004 through 2008 under paragraph 
        (1).

SEC. 303. ASSISTANCE TO COMBAT MALARIA.

    (a) Amendment of the Foreign Assistance Act of 1961.--Chapter 1 of 
part I of the Foreign Assistance Act of 1961 (22 U.S.C. 2151 et seq.), 
as amended by sections 301 and 302 of this Act, is further amended by 
inserting after section 104B the following new section:

``SEC. 104C. ASSISTANCE TO COMBAT MALARIA.

    ``(a) Finding.--Congress finds that malaria kills more people 
annually than any other communicable disease except tuberculosis, that 
more than 90 percent of all malaria cases are in sub-Saharan Africa, 
and that children and women are particularly at risk. Congress 
recognizes that there are cost-effective tools to decrease the spread 
of malaria and that malaria is a curable disease if promptly diagnosed 
and adequately treated.
    ``(b) Policy.--It is a major objective of the foreign assistance 
program of the United States to provide assistance for the prevention, 
control, and cure of malaria.
    ``(c) Authorization.--To carry out this section and consistent with 
section 104(c), the President is authorized to furnish assistance, on 
such terms and conditions as the President may determine, for the 
prevention, treatment, control, and elimination of malaria.
    ``(d) Coordination.--In carrying out this section, the President 
shall coordinate with the World Health Organization, the Global Fund to 
Fight AIDS, Tuberculosis, and Malaria, the Department of Health and 
Human Services (the Centers for Disease Control and Prevention and the 
National Institutes of Health), and other organizations with respect to 
the development and implementation of a comprehensive malaria control 
program.''.
    (b) Authorization of Appropriations.--
            (1) In general.--In addition to funds available under 
        section 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C. 
        2151b(c)) for such purpose or under any other provision of that 
        Act, there are authorized to be appropriated to the President, 
        from amounts authorized to be appropriated under section 401, 
        such sums as may be necessary for fiscal years 2004 through 
2008 to carry out section 104C of the Foreign Assistance Act of 1961, 
as added by subsection (a), including for the development of anti-
malarial pharmaceuticals by the Medicines for Malaria Venture.
            (2) Availability of funds.--Amounts appropriated pursuant 
        to paragraph (1) are authorized to remain available until 
        expended.
            (3) Transfer of prior year funds.--Unobligated balances of 
        funds made available for fiscal year 2001, 2002, or 2003 under 
        section 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C. 
        2151b(c) (as in effect immediately before the date of enactment 
        of this Act) and made available for the control of malaria 
        shall be transferred to, merged with, and made available for 
        the same purposes as funds made available for fiscal years 2004 
        through 2008 under paragraph (1).
    (c) Conforming Amendment.--Section 104(c) of the Foreign Assistance 
Act of 1961 (22 U.S.C. 2151b(c)), as amended by section 301 of this 
Act, is further amended by adding after paragraph (3) the following:
    ``(4) Relationship to other laws.--Assistance made available under 
this subsection and sections 104A, 104B, and 104C, and assistance made 
available under chapter 4 of part II to carry out the purposes of this 
subsection and the provisions cited in this paragraph, may be made 
available notwithstanding any other provision of law that restricts 
assistance to foreign countries, except for the provisions of this 
subsection, the provisions of law cited in this paragraph, subsection 
(f), section 634A of this Act, and provisions of law that limit 
assistance to organizations that support or participate in a program of 
coercive abortion or involuntary sterilization included under the Child 
Survival and Health Programs Fund heading in the Consolidated 
Appropriations Resolution, 2003 (Public Law 108-7).''.

SEC. 304. PILOT PROGRAM FOR THE PLACEMENT OF HEALTH CARE PROFESSIONALS 
              IN OVERSEAS AREAS SEVERELY AFFECTED BY HIV/AIDS, 
              TUBERCULOSIS, AND MALARIA.

    (a) In General.--The President should establish a program to 
demonstrate the feasibility of facilitating the service of United 
States health care professionals in those areas of sub-Saharan Africa 
and other parts of the world severely affected by HIV/AIDS, 
tuberculosis, and malaria.
    (b) Requirements.--Participants in the program shall--
            (1) provide basic health care services for those infected 
        and affected by HIV/AIDS, tuberculosis, and malaria in the area 
        in which they are serving;
            (2) provide on-the-job training to medical and other 
        personnel in the area in which they are serving to strengthen 
        the basic health care system of the affected countries;
            (3) provide health care educational training for residents 
        of the area in which they are serving;
            (4) serve for a period of up to three years; and
            (5) meet the eligibility requirements in subsection (d).
    (c) Eligibility Requirements.--To be eligible to participate in the 
program, a candidate shall--
            (1) be a national of the United States who is a trained 
        health care professional and who meets the educational and 
        licensure requirements necessary to be such a professional such 
        as a physician, nurse, physician assistant, nurse practitioner, 
        pharmacist, other type of health care professional, or other 
        individual determined to be appropriate by the President; or
            (2) be a retired commissioned officer of the Public Health 
        Service Corps.
    (d) Recruitment.--The President shall ensure that information on 
the program is widely distributed, including the distribution of 
information to schools for health professionals, hospitals, clinics, 
and nongovernmental organizations working in the areas of international 
health and aid.
    (e) Placement of Participants.--
            (1) In general.--To the maximum extent practicable, 
        participants in the program shall serve in the poorest areas of 
        the affected countries, where health care needs are likely to 
        be the greatest. The decision on the placement of a participant 
        should be made in consultation with relevant officials of the 
        affected country at both the national and local level as well 
        as with local community leaders and organizations.
            (2) Coordination.--Placement of participants in the program 
        shall be coordinated with the United States Agency for 
        International Development in countries in which that Agency is 
        conducting HIV/AIDS, tuberculosis, or malaria programs. Overall 
        coordination of placement of participants in the program shall 
        be made by the Coordinator of United States Government 
        Activities to Combat HIV/AIDS Globally (as described in section 
        1(f) of the State Department Basic Authorities Act of 1956 (as 
        added by section 102(a) of this Act)).
    (f) Incentives.--The President may offer such incentives as the 
President determines to be necessary to encourage individuals to 
participate in the program, such as partial payment of principal, 
interest, and related expenses on government and commercial loans for 
educational expenses relating to professional health training and, 
where possible, deferment of repayments on such loans, the provision of 
retirement benefits that would otherwise be jeopardized by 
participation in the program, and other incentives.
    (g) Report.--Not later than 18 months after the date of enactment 
of this Act, the President shall submit to the appropriate 
congressional committees a report on steps taken to establish the 
program, including--
            (1) the process of recruitment, including the venues for 
        recruitment, the number of candidates recruited, the incentives 
        offered, if any, and the cost of those incentives;
            (2) the process, including the criteria used, for the 
        selection of participants;
            (3) the number of participants placed, the countries in 
        which they were placed, and why those countries were selected; 
        and
            (4) the potential for expansion of the program.
    (h) Authorization of Appropriations.--
            (1) In general.--In addition to amounts otherwise available 
        for such purpose, there are authorized to be appropriated to 
        the President, from amounts authorized to be appropriated under 
        section 401, such sums as may be necessary for each of the 
        fiscal years 2004 through 2008 to carry out the program.
            (2) Availability of funds.--Amounts appropriated pursuant 
        to the authorization of appropriations under paragraph (1) are 
        authorized to remain available until expended.

SEC. 305. REPORT ON TREATMENT ACTIVITIES BY RELEVANT EXECUTIVE BRANCH 
              AGENCIES.

    (a) In General.--Not later than 15 months after the date of 
enactment of this Act, the President shall submit to appropriate 
congressional committees a report on the programs and activities of the 
relevant executive branch agencies that are directed to the treatment 
of individuals in foreign countries infected with HIV or living with 
AIDS.
    (b) Report Elements.--The report shall include--
            (1) a description of the activities of relevant executive 
        branch agencies with respect to--
                    (A) the treatment of opportunistic infections;
                    (B) the use of antiretrovirals;
                    (C) the status of research into successful 
                treatment protocols for individuals in the developing 
                world;
                    (D) technical assistance and training of local 
                health care workers (in countries affected by the 
                pandemic) to administer antiretrovirals, manage side 
                effects, and monitor patients' viral loads and immune 
                status;
                    (E) the status of strategies to promote 
                sustainability of HIV/AIDS pharmaceuticals (including 
                antiretrovirals) and the effects of drug resistance on 
                HIV/AIDS patients; and
                    (F) the status of appropriate law enforcement 
                officials working to ensure that HIV/AIDS 
                pharmaceutical treatment is not diminished through 
                illegal counterfeiting and black market sales of such 
                pharmaceuticals;
            (2) information on existing pilot projects, including a 
        discussion of why a given population was selected, the number 
        of people treated, the cost of treatment, the mechanisms 
        established to ensure that treatment is being administered 
        effectively and safely, and plans for scaling up pilot projects 
        (including projected timelines and required resources); and
            (3) an explanation of how those activities relate to 
        efforts to prevent the transmission of the HIV infection.

            Subtitle B--Assistance for Children and Families

SEC. 311. FINDINGS.

    Congress makes the following findings:
            (1) Approximately 2,000 children around the world are 
        infected each day with HIV through mother-to-child 
        transmission. Transmission can occur during pregnancy, labor, 
        and delivery or through breast feeding. Over ninety percent of 
        these cases are in developing nations with little or no access 
        to public health facilities.
            (2) Mother-to-child transmission is largely preventable 
        with the proper application of pharmaceuticals, therapies, and 
        other public health interventions.
            (3) The drug nevirapine reduces mother-to-child 
        transmission by nearly 50 percent. Universal availability of 
        this drug could prevent up to 400,000 infections per year and 
        dramatically reduce the number of AIDS-related deaths.
            (4) At the United Nations Special Session on HIV/AIDS in 
        June 2001, the United States committed to the specific goals 
        with respect to the prevention of mother-to-child transmission, 
        including the goals of reducing the proportion of infants 
        infected with HIV by 20 percent by the year 2005 and by 50 
        percent by the year 2010, as specified in the Declaration of 
        Commitment on HIV/AIDS adopted by the United Nations General 
        Assembly at the Special Session.
            (5) Several United States Government agencies including the 
        United States Agency for International Development and the 
        Centers for Disease Control are already supporting programs to 
        prevent mother-to-child transmission in resource-poor nations 
        and have the capacity to expand these programs rapidly by 
        working closely with foreign governments and nongovernmental 
        organizations.
            (6) Efforts to prevent mother-to-child transmission can 
        provide the basis for a broader response that includes care and 
        treatment of mothers, fathers, and other family members who are 
        infected with HIV or living with AIDS.
            (7) HIV/AIDS has devastated the lives of countless children 
        and families across the globe. Since the epidemic began, an 
        estimated 13,200,000 children under the age of 15 have been 
        orphaned by AIDS, that is they have lost their mother or both 
        parents to the disease. The Joint United Nations Program on 
        HIV/AIDS (UNAIDS) estimates that this number will double by the 
        year 2010.
            (8) HIV/AIDS also targets young people between the ages of 
        15 to 24, particularly young women, many of whom carry the 
        burden of caring for family members living with HIV/AIDS. An 
        estimated 10,300,000 young people are now living with HIV/AIDS. 
        One-half of all new infections are occurring among this age 
        group.

SEC. 312. POLICY AND REQUIREMENTS.

    (a) Policy.--The United States Government's response to the global 
HIV/AIDS pandemic should place high priority on the prevention of 
mother-to-child transmission, the care and treatment of family members 
and caregivers, and the care of children orphaned by AIDS. To the 
maximum extent possible, the United States Government should seek to 
leverage its funds by seeking matching contributions from the private 
sector, other national governments, and international organizations.
    (b) Requirements.--The 5-year United States Government strategy 
required by section 101 of this Act shall--
            (1) provide for meeting or exceeding the goal to reduce the 
        rate of mother-to-child transmission of HIV by 20 percent by 
2005 and by 50 percent by 2010;
            (2) include programs to make available testing and 
        treatment to HIV-positive women and their family members, 
        including drug treatment and therapies to prevent mother-to-
        child transmission; and
            (3) expand programs designed to care for children orphaned 
        by AIDS.

SEC. 313. ANNUAL REPORTS ON PREVENTION OF MOTHER-TO-CHILD TRANSMISSION 
              OF THE HIV INFECTION.

    (a) In General.--Not later than one year after the date of the 
enactment of this Act, and annually thereafter for a period of five 
years, the President shall submit to appropriate congressional 
committees a report on the activities of relevant executive branch 
agencies during the reporting period to assist in the prevention of 
mother-to-child transmission of the HIV infection.
    (b) Report Elements.--Each report shall include--
            (1) a statement of whether or not all relevant executive 
        branch agencies have met the goal described in section 
        312(b)(1); and
            (2) a description of efforts made by the relevant executive 
        branch agencies to expand those activities, including--
                    (A) information on the number of sites supported 
                for the prevention of mother-to-child transmission of 
                the HIV infection;
                    (B) the specific activities supported;
                    (C) the number of women tested and counseled; and
                    (D) the number of women receiving preventative drug 
                therapies.
    (c) Reporting Period Defined.--In this section, the term 
``reporting period'' means, in the case of the initial report, the 
period since the date of enactment of this Act and, in the case of any 
subsequent report, the period since the date of submission of the most 
recent report.

SEC. 314. PILOT PROGRAM OF ASSISTANCE FOR CHILDREN AND FAMILIES 
              AFFECTED BY HIV/AIDS.

    (a) In General.--The President, acting through the United States 
Agency for International Development, should establish a program of 
assistance that would demonstrate the feasibility of the provision of 
care and treatment to orphans and other children and young people 
affected by HIV/AIDS in foreign countries.
    (b) Program Requirements.--The program should--
            (1) build upon and be integrated into programs administered 
        as of the date of enactment of this Act by the relevant 
        executive branch agencies for children affected by HIV/AIDS;
            (2) work in conjunction with indigenous community-based 
        programs and activities, particularly those that offer proven 
        services for children;
            (3) reduce the stigma of HIV/AIDS to encourage vulnerable 
        children infected with HIV or living with AIDS and their family 
        members and caregivers to avail themselves of voluntary 
        counseling and testing, and related programs, including 
        treatments;
            (4) provide, in conjunction with other relevant executive 
        branch agencies, the range of services for the care and 
        treatment, including the provision of antiretrovirals and other 
        necessary pharmaceuticals, of children, parents, and caregivers 
        infected with HIV or living with AIDS;
            (5) provide nutritional support and food security, and the 
        improvement of overall family health;
            (6) work with parents, caregivers, and community-based 
        organizations to provide children with educational 
        opportunities; and
            (7) provide appropriate counseling and legal assistance for 
        the appointment of guardians and the handling of other issues 
        relating to the protection of children.
    (c) Report.--Not later than 18 months after the date of enactment 
of this Act, the President should submit a report on the implementation 
of this section to the appropriate congressional committees.
    (d) Authorization of Appropriations.--
            (1) In general.--In addition to amounts otherwise available 
        for such purpose, there are authorized to be appropriated to 
        the President, from amounts authorized to be appropriated under 
        section 401, such sums as may be necessary for each of the 
        fiscal years 2004 through 2008 to carry out the program.
            (2) Availability of funds.--Amounts appropriated pursuant 
        to paragraph (1) are authorized to remain available until 
        expended.

SEC. 315. PILOT PROGRAM ON FAMILY SURVIVAL PARTNERSHIPS.

    (a) Purpose.--The purpose of this section is to authorize the 
President to establish a program, through a public-private partnership, 
for the provision of medical care and support services to HIV positive 
parents and their children identified through existing programs to 
prevent mother-to-child transmission of HIV in countries with or at 
risk for severe HIV epidemic with particular attention to resource 
constrained countries.
    (b) Grants.--
            (1) In general.--The President is authorized to establish a 
        program for the award of grants to eligible administrative 
        organizations to enable such organizations to award subgrants 
        to eligible entities to expand activities to prevent the 
        mother-to-child transmission of HIV by providing medical care 
        and support services to HIV infected parents and their 
        children.
            (2) Use of funds.--Amounts provided under a grant awarded 
        under paragraph (1) shall be used--
                    (A) to award subgrants to eligible entities to 
                enable such entities to carry out activities described 
                in subsection (c);
                    (B) for administrative support and subgrant 
                management;
                    (C) for administrative data collection and 
                reporting concerning grant activities;
                    (D) for the monitoring and evaluation of grant 
                activities;
                    (E) for training and technical assistance for 
                subgrantees; and
                    (F) to promote sustainability.
    (c) Subgrants.--
            (1) In general.--An organization awarded a grant under 
        subsection (b) shall use amounts received under the grant to 
award subgrants to eligible entities.
            (2) Eligibility.--To be eligible to receive a subgrant 
        under paragraph (1), an entity shall--
                    (A) be a local health organization, an 
                international organization, or a partnership of such 
                organizations; and
                    (B) demonstrate to the awarding organization that 
                such entity--
                            (i) is currently administering a proven 
                        intervention to prevent mother-to-child 
                        transmission of HIV in countries with or at 
                        risk for severe HIV epidemic with particular 
                        attention to resource constrained countries, as 
                        determined by the President;
                            (ii) has demonstrated support for the 
                        proposed program from relevant government 
                        entities; and
                            (iii) is able to provide HIV care, 
                        including antiretroviral treatment when 
                        medically indicated, to HIV positive women, 
                        men, and children with the support of the 
                        project funding.
            (3) Local health and international organizations.--For 
        purposes of paragraph (2)(A)--
                    (A) the term ``local health organization'' means a 
                public sector health system, nongovernmental 
                organization, institution of higher education, 
                community-based organization, or nonprofit health 
                system that provides directly, or has a clear link with 
                a provider for the indirect provision of, primary 
                health care services; and
                    (B) the term ``international organization'' means--
                            (i) a nonprofit international entity;
                            (ii) an international charitable 
                        institution;
                            (iii) a private voluntary international 
                        entity; or
                            (iv) a multilateral institution.
            (4) Priority requirement.--In awarding subgrants under this 
        subsection, the organization shall give priority to eligible 
        applicants that are currently administering a program of proven 
        intervention to HIV positive individuals to prevent mother-to-
        child transmission in countries with or at risk for severe HIV 
        epidemic with particular attention to resource constrained 
        countries, and who are currently administering a program to HIV 
        positive women, men, and children to provide life-long care in 
        family-centered care programs using non-Federal funds.
            (5) Selection of subgrant recipients.--In awarding 
        subgrants under this subsection, the organization should--
                    (A) consider applicants from a range of health care 
                settings, program approaches, and geographic locations; 
                and
                    (B) if appropriate, award not less than 1 grant to 
                an applicant to fund a national system of health care 
                delivery to HIV positive families.
            (6) Use of subgrant funds.--An eligible entity awarded a 
        subgrant under this subsection shall use subgrant funds to 
        expand activities to prevent mother-to-child transmission of 
        HIV by providing medical treatment and care and support 
        services to parents and their children, which may include--
                    (A) providing treatment and therapy, when medically 
                indicated, to HIV-infected women, their children, and 
                families;
                    (B) the hiring and training of local personnel, 
                including physicians, nurses, other health care 
                providers, counselors, social workers, outreach 
                personnel, laboratory technicians, data managers, and 
                administrative support personnel;
                    (C) paying laboratory costs, including costs 
                related to necessary equipment and diagnostic testing 
                and monitoring (including rapid testing), complete 
                blood counts, standard chemistries, and liver function 
                testing for infants, children, and parents, and costs 
                related to the purchase of necessary laboratory 
                equipment;
                    (D) purchasing pharmaceuticals for HIV-related 
                conditions, including antiretroviral therapies;
                    (E) funding support services, including adherence 
                and psychosocial support services;
                    (F) operational support activities; and
                    (G) conducting community outreach and capacity 
                building activities, including activities to raise the 
                awareness of individuals of the program carried out by 
                the subgrantee, other communications activities in 
                support of the program, local advisory board functions, 
                and transportation necessary to ensure program 
                participation.
    (d) Reports.--The President shall require that each organization 
awarded a grant under subsection (b)(1) to submit an annual report that 
includes--
            (1) the progress of programs funded under this section;
            (2) the benchmarks of success of programs funded under this 
        section; and
            (3) recommendations of how best to proceed with the 
        programs funded under this section upon the expiration of 
        funding under subsection (e).
    (e) Funding.--There are authorized to be appropriated to the 
President, from amounts authorized to be appropriated under section 
401, such sums as may be necessary for each of the fiscal years 2004 
through 2008 to carry out the program.
    (f) Limitation on Administrative Expenses.--An organization shall 
ensure that not more than 7 percent of the amount of a grant received 
under this section by the organization is used for administrative 
expenses.

               TITLE IV--AUTHORIZATION OF APPROPRIATIONS

SEC. 401. AUTHORIZATION OF APPROPRIATIONS.

    (a) In General.--There are authorized to be appropriated to the 
President to carry out this Act and the amendments made by this Act 
$3,000,000,000 for each of the fiscal years 2004 through 2008.
    (b) Availability.--Amounts appropriated pursuant to the 
authorization of appropriations in subsection (a) are authorized to 
remain available until expended.
    (c) Availability of Authorizations.--Authorizations of 
appropriations under subsection (a) shall remain available until the 
appropriations are made.

SEC. 402. SENSE OF CONGRESS.

    (a) Increase in HIV/AIDS Antiretroviral Treatment.--It is a sense 
of the Congress that an urgent priority of United States assistance 
programs to fight HIV/AIDS should be the rapid increase in distribution 
of antiretroviral treatment so that--
            (1) by the end of fiscal year 2004, at least 500,000 
        individuals with HIV/AIDS are receiving antiretroviral 
        treatment through United States assistance programs;
            (2) by the end of fiscal year 2005, at least 1,000,000 such 
        individuals are receiving such treatment; and
            (3) by the end of fiscal year 2006, at least 2,000,000 such 
        individuals are receiving such treatment.
    (b) Effective Distribution of HIV/AIDS Funds.--It is the sense of 
Congress that, of the amounts appropriated pursuant to the 
authorization of appropriations under section 401 for HIV/AIDS 
assistance, an effective distribution of such amounts would be--
            (1) 55 percent of such amounts for treatment of individuals 
        with HIV/AIDS;
            (2) 15 percent of such amounts for palliative care of 
        individuals with HIV/AIDS;
            (3) 20 percent of such amounts for HIV/AIDS prevention 
        consistent with section 104A(d) of the Foreign Assistance Act 
        of 1961 (as added by section 301 of this Act); and
            (4) 10 percent of such amounts for orphans and vulnerable 
        children.

SEC. 403. ALLOCATION OF FUNDS.

    For fiscal years 2006 through 2008, not less than 55 percent of the 
amounts appropriated pursuant to the authorization of appropriations 
under section 401 for HIV/AIDS assistance for each such fiscal year 
shall be expended for therapeutic medical care of individuals infected 
with HIV, of which such amount at least 75 percent should be expended 
for the purchase and distribution of antiretroviral pharmaceuticals and 
at least 25 percent should be expended for related care.




                                                  Union Calendar No. 38

108th CONGRESS

  1st Session

                               H. R. 1298

                          [Report No. 108-60]

_______________________________________________________________________

                                 A BILL

    To provide assistance to foreign countries to combat HIV/AIDS, 
           tuberculosis, and malaria, and for other purposes.

_______________________________________________________________________

                             April 7, 2003

  Reported with an amendment, committed to the Committee of the Whole 
       House on the State of the Union, and ordered to be printed